MoonLake Immunotherapeutics (MLTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 849.63M |
| Enterprise Value | 590.83M |
| P/E Ratio | -3.67 |
| PEG Ratio | 0.33 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.02 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.36 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.51 |
| Return On Equity | -0.8 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -2.62M |
| EBITDA | -219.85M |
| Net Income | -227.32M |
| Diluted EPS | -3.53 |
| Total Cash | 498.46M |
| Total Cash/Share | 5.84 |
| Total Debt | 101.62M |
| Total Debt/Equity | 0.27 |
| Current Ratio | 9.13 |
| Book Value Per Share | 4.47 |
| 52-Week Change | 14.98 |
| 52-Week High | 23.29 |
| 52-Week Low | 9.46 |
| Moving Average 50 Days | 12.01 |
| Moving Average 200 Days | 16.31 |
| Average Volume | 1.64M |
| Shares Outstanding | 85.11M |
| % Held by Institutions | 102.76 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |